Endoglin Expression in Melanoma
Author Information
Author(s): M Altomonte, R Montagner, E Fonsatti, F Colizzi, I Cattarossi, LI Brasoveanu, MR Nicotra, A Cattelan, PG Natali, M Maio
Primary Institution: Centro di Riferimento Oncologico, Aviano, Italy
Hypothesis
Does endoglin (CD105) play a role in the growth regulation of melanoma cells by binding TGF-beta?
Conclusion
Endoglin is expressed in melanoma cells and can regulate their growth in response to TGF-beta.
Supporting Evidence
- CD105 is expressed on normal and neoplastic cells of the melanocytic lineage.
- 50% of intradermal naevi, 25% of primary melanomas, and 34% of metastatic melanomas were positive for CD105.
- Exogenous TGF-beta1 significantly inhibited the growth of CD105-positive melanoma cells.
Takeaway
This study found that a protein called endoglin is present in melanoma cells and helps control their growth when a specific growth factor is added.
Methodology
Immunohistochemical analyses and SDS-PAGE were used to study endoglin expression and its binding to TGF-beta in melanoma cells.
Limitations
The study did not explore the expression of TGF-beta receptors in melanoma cells.
Participant Demographics
Patients with benign naevi and melanoma lesions.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website